The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche et al. · BMJ · 2011 · 34.2K citations · Full text

Public Health, Biostatistics, Evidence-based Practice +16

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon Guyatt, Andrew D Oxman, Gunn Elisabeth Vist et al. · BMJ · 2008 · 22.1K citations · Full text

Education, Educational Assessment, Evidence-based Practice +8

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves et al. · BMJ · 2016 · 19K citations · Full text

Public Health, Biostatistics, Health Services Research +15

Elevated C-Reactive Protein Levels in Overweight and Obese Adults

Marjolein Visser · JAMA · 1999 · 2.5K citations

Veterinary Medicine, Immunology, Nutrition +14

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos et al. · Annals of the Rheumatic Diseases · 2009 · 1.6K citations

Medicine, Clinical Sciences, Radiology +14